Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata

Fertility and Sterility

Volumn 67, Issue 5, 1997, Pages 837-841

  Deligdisch, Liane ^a   Hirschmann, Scott ^b   Altchek, Albert ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b City Hospital at Elmhurst   (United States)

Author keywords

GnRH agonist analogue therapy; nodular hyalinization; Uterine leiomyoma

Indexed keywords

GONADORELIN AGONIST; GONADORELIN DERIVATIVE; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; HYSTERECTOMY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; TISSUE SECTION; TUMOR NECROSIS; TUMOR VOLUME; UTERUS MYOMA; UTERUS WEIGHT;

EID: 0030895465     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81394-5     Document Type: Article

References (19)

1. Adamson, GD. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 1992; 166:746-51.
2. Watanabe Y, Nakamura G, Matsuguchi H, Nozaki M, Sano M, Nakano H. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Fertil Steril 1992;58:66-71.
3. Van Leusden HA. Symptom-free interval after triptorelin treatment of uterine fibroids: long-term results. Gynecol Endocrinol 1992;6:189-98.
4. Friedman AJ, Daly M, Juneau-Norcross M, Rein MS. Predictions of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertil Steril 1992;58:413-5.
5. Hackenberg R, Gesenhues T, Deichert U, Duda V, Schmidt-Rhode P, Schultz KD. The response of uterine fibroids to GnRH agonist treatment can be predicted in most cases after a month. Eur J Obstet Gynecol Reprod Biol 1992;45:125-9.
6. Friedman AJ, Lobel SM, Rein MS, Barbieri RL. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypotheses. Am J Obstet Gynecol 1990; 163:1114-9.
7. Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD. The Leuprolide Study Group. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled multicenter study. Obstet Gynecol 1991; 77:7205.
8. Friedman AJ, Daly J, Juneau-Norcross M, Rein MS, Fine C, Gleason R, et al. A prospective randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" regimens for women with leiomyomata uteri. J Clin Endocrinol Metab 1993;76:1439-45.
9. Friedman AJ, Harrison-Atlas D, Barbieri RL, Benaceraff B, Gleason R, Schiff I. A randomized, placebo-controlled double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril 1989; 51:251-6.
10. Friedman AJ, Rein MS, Harrison-Atlas D, Garfield JM, Doubilet PM. A randomized, placebo-controlled double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 1989;52:728-33.
11. Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 1990;53:1018-23.
12. Upadhyaya NB, Doody MC, Googe PB. Histopathological changes in leiomyomata treated with leuprolide acetate. Fertil Steril 1990;54:811-4.
13. Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyoma following treatment with gonadotropinreleasing hormone analogues. Hum Pathol 1993;24:1073-7.
14. Rutgers JL, Spong CY, Sinow R, Heiner J. Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 1995; 86:386-8.
15. Crow J, Gardner RL, McSweeney G, Shaw RW. Morphological changes in uterine leiomyomas treated by GnRH agonist Goserelin. Int J Gynecol Pathol 1995; 14:235-42.
16. Gutmann JN, Thornton KL, Diamond MP, Carcangiu ML. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata. Fertil Steril 1994;61:622-6.
17. Sreenan JJ, Prayson RA, Biscotti CV, Thornton MH, Easley KA, Hart WR. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. Am J Surg Pathol 1996;20:427-32.
18. Kiltz, RJ, Rutgers J, Phillips J, Murugusapillai ML, Kletzky OA. Absence of a dose-response effect of leuprolide acetate on leiomyomata uteri size. Fertil Steril 1994;61:1021-6.
19. Rein MS, Barbieri RL, Welch W, Gleason RE, Caulfield JP, Friedman AJ. The concentration of collagen associated amino acids are higher in GnRH agonist treated uterine leiomyomata. Fertil Steril 1989;51:251-6.